Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps (Yasargil-1)
Study Details
Study Description
Brief Summary
Although several studies have demonstrated the overall benefits of a laparoscopic approach for pelvic and para-aortic lymphadenectomy, complications remain a challenging scenario. Vascular injury occurs in 0.3% to 1.0% of laparoscopic procedures, with potentially lethal consequences. Vascular injuries are usually managed using coagulation, clamps or vascular sutures, but if these measures fail, laparotomy is inevitable.
To date, few reports evaluated the use of minimally invasive surgery for lymph node debulking in gynecological cancer patients with metastatic bulky lymph nodes, with encouraging results, despite the small sample sizes. Nevertheless, new minimally invasive surgery techniques that may minimize intraoperative complications are necessary. Considering these elements, this multicenter retrospective analysis is aimed to evaluate intra- and post-operative surgical outcomes, after laparoscopic ultraradical lymph nodal debulking using Yasargil clamps in gynecological cancer patients with bulky lymph node metastases.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Women affected by gynecological cancer Women affected by gynecological cancer (cervical, endometrial, ovarian and vulvar cancer) |
Procedure: Laparoscopic ultra-radical lymph node debulking
Laparoscopic ultra-radical lymph node debulking using Yasargil clamps
|
Outcome Measures
Primary Outcome Measures
- Complications [During the surgery and within 30 days after the surgery]
Any complication occurred
Eligibility Criteria
Criteria
Inclusion Criteria:
-
At least one bulky lymph node with size ≥ 25 mm
-
Age > 18 years
-
Body mass index (BMI) < 40 kg/m²
-
Absence of abdominal adhesion syndrome and intraperitoneal dissemination at the time of laparoscopic evaluation
Exclusion Criteria:
-
Disease-free interval < 6 months and/or
-
Performance status > 2 according to Eastern Cooperative Oncology Group (ECOG) criteria
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Palermo | Palermo | Sicily | Italy | 90133 |
Sponsors and Collaborators
- University of Palermo
- Fondazione Policlinico Universitario A. Gemelli, IRCCS
- Universita di Verona
Investigators
- Study Chair: Antonio Simone Laganà, M.D., Ph.D., University of Palermo
- Study Director: Vito Chiantera, University of Palermo
- Principal Investigator: Mariano Catello Di Donna, University of Palermo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Yasargil-1